Navigation Links
Anti-Nuclear Antibody (ANA) with Reflex to dsDNA, RNP, Smith, SSA, & SSB Antibodies

ProductsAnti-Nuclear Antibody (ANA) with Reflex to dsDNA, RNP, Smith, SSA, & SSB Antibodies
Company ARUP Laboratories
Item Anti-Nuclear Antibody (ANA) with Reflex to dsDNA, RNP, Smith, SSA, & SSB Antibodies
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. ImmuLisa Anti-Nuclear Antibody (ANA) Screen ELISA
2. Anti-Nuclear Antibodies (ANA), IgG Screen with Reflex to IFA Titer
3. Anti-Nuclear Antibodies (ANA) Hep-2 Substrate
4. OraQuick ADVANCE Rapid HIV-1/2 Antibody Test
5. Reveal Rapid HIV-1 Antibody Test
6. Wampole PreVue B. Burgdorferi Antibody Detection Assay
7. BioSign® Mono - Rapid Infectious Mononucleosis Heterophile Antibody (IgM) Test
8. OraQuick Rapid HIV-1 Antibody Test
9. FlexSure HP Helicobacter Pylori Antibody Test
10. BioSign® H. pylori - Rapid H. pylori Antibody (IgM/IgG/IgA) Test
11. Double Antibody Estradiol RIA
Breaking Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 62585 1Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 62585 2Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 62585 3Senate Approval of Mikulski Amendment Further Opens Health Care Bill to Massive Federal Funding of Abortion 62581 1Senate Approval of Mikulski Amendment Further Opens Health Care Bill to Massive Federal Funding of Abortion 62581 2Ginger Prices Could Skyrocket on H1N1 Fears 62576 1Ginger Prices Could Skyrocket on H1N1 Fears 62576 2